Back
Grifols SA Vs. Laboratorios Farmaceuticos Rovi SA Industry Stock Comparison
Buy
86
GIKLY
Grifols SA
Last Price:
5.51
Seasonality Move:
2.6%
Buy
57
LABFF
Laboratorios Farmaceuticos Rovi SA
Last Price:
86.05
Seasonality Move:
56752.38%
Buy
86
Grifols SA (GIKLY)
is a Buy
Is Grifols SA a Buy, Sell or Hold?
- The current Grifols SA [GIKLY] share price is $5.46. The Score for GIKLY is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- GIKLY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
57
Laboratorios Farmaceuticos Rovi SA (LABFF)
is a Buy
Is Laboratorios Farmaceuticos Rovi SA a Buy, Sell or Hold?
- The current Laboratorios Farmaceuticos Rovi SA [LABFF] share price is $86.05. The Score for LABFF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- LABFF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GIKLY Stock Price Chart
What is Grifols SA's stock price today?
-
The Grifols SA share price today is $5.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GIKLY is experiencing slight buying pressure.
LABFF Stock Price Chart
What is Laboratorios Farmaceuticos Rovi SA's stock price today?
-
The Laboratorios Farmaceuticos Rovi SA share price today is $86.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LABFF is experiencing slight buying pressure.
GIKLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 70.72 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.37 - 5.09) | Buy |
| Bollinger Bands (100): | (4.14 - 6.38) | Buy |
LABFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.77 | Buy |
| Relative Strength Index (14 RSI): | 99.99 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.05 - 86.05) | Sell |
| Bollinger Bands (100): | (51.66 - 85.7) | Buy |
GIKLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.14 | Buy |
| 20-day SMA: | 4.73 | Buy |
| 50-day SMA: | 4.56 | Buy |
| 200-day SMA: | 5.95 | Sell |
| 8-day EMA: | 5.15 | Buy |
| 20-day EMA: | 4.89 | Buy |
| 50-day EMA: | 4.86 | Buy |
| 200-day EMA: | 5.61 | Sell |
LABFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 86.05 | Sell |
| 20-day SMA: | 86.05 | Sell |
| 50-day SMA: | 85.37 | Buy |
| 200-day SMA: | 60.49 | Buy |
| 8-day EMA: | 86.05 | Buy |
| 20-day EMA: | 85.8 | Buy |
| 50-day EMA: | 81.26 | Buy |
| 200-day EMA: | 65.18 | Buy |
Grifols SA Earnings Growth & GIKLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Laboratorios Farmaceuticos Rovi SA Earnings Growth & LABFF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Grifols SA Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Laboratorios Farmaceuticos Rovi SA Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||